Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-18 Sale | 2024-11-20 4:39 pm | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 17,000 | $21.04 | $357,680 | 118,992 (Direct) | View |
2024-11-06 Sale | 2024-11-08 4:34 pm | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 89,561 | $23 | $2,059,903 | 199,371 (Indirect Direct) | View |
2024-10-15 Sale | 2024-10-17 4:35 pm | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 17,000 | $26.87 | $456,790 | 135,992 (Direct) | View |
2024-09-23 Sale | 2024-09-25 4:39 pm | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 17,500 | $24.99 | $437,325 | 152,992 (Direct) | View |
2024-09-03 Sale | 2024-09-04 8:52 pm | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 60,692 | $26.12 | $1,584,991 | 151,529 (Direct) | View |
2024-09-03 Sale | 2024-09-04 8:42 pm | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 68,506 | $26.12 | $1,789,190 | 125,037 (Direct) | View |
2024-08-27 Sale | 2024-08-29 4:36 pm | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 17,500 | $26.91 | $470,925 | 165,928 (Direct) | View |
2024-07-23 Sale | 2024-07-25 4:33 pm | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 136,124 | $25.65 | $3,491,947 | 361,954 (Indirect Direct) | View |
2024-07-23 Sale | 2024-07-25 4:32 pm | Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 24,248 | $24.79 | $601,108 | 59,665 (Direct) | View |
2024-07-23 Sale | 2024-07-25 4:31 pm | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 22,000 | $26.32 | $578,966 | 108,020 (Direct) | View |
2024-03-07 Sale | 2024-03-11 7:05 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 65,012 | $21.02 | $1,366,552 | 162,311 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-18 Exercise | 2024-11-20 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $1.59 | 118,992 (Direct) | View |
2024-11-18 Exercise | 2024-11-20 4:39 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $0 | 118,992 (Direct) | View |
2024-11-07 Option Award | 2024-11-12 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Levy Richard S Director | 1,303 | $0 | 15,503 (Direct) | View |
2024-11-07 Exercise | 2024-11-12 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Levy Richard S Director | 1,303 | $0 | 15,503 (Direct) | View |
2024-11-06 Exercise | 2024-11-08 4:34 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 89,561 | $1.59 | 199,371 (Direct) | View |
2024-11-06 Exercise | 2024-11-08 4:34 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 89,561 | $0 | 199,371 (Direct) | View |
2024-10-15 Exercise | 2024-10-17 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $1.59 | 135,992 (Direct) | View |
2024-10-15 Exercise | 2024-10-17 4:35 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $0 | 135,992 (Direct) | View |
2024-10-04 Tax Withholding | 2024-10-08 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 82 | $24.48 | 26,703 (Direct) | View |
2024-10-04 Exercise | 2024-10-08 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 175 | $0 | 26,703 (Direct) | View |
2024-10-04 Option Award | 2024-10-08 4:14 pm | N/A 2034-10-03 | Kiniksa Pharmaceuticals International plc | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 61,498 | $0 | 2,816,867 (Indirect) | View |
2024-09-23 Exercise | 2024-09-25 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $1.59 | 152,992 (Direct) | View |
2024-09-23 Exercise | 2024-09-25 4:39 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $0 | 152,992 (Direct) | View |
2024-09-01 Option Award | 2024-09-04 8:57 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 28,350 | $0 | 71,096 (Direct) | View |
2024-09-01 Tax Withholding | 2024-09-04 8:57 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 3,084 | $26.74 | 71,096 (Direct) | View |
2024-07-15 Option Award | 2024-09-04 8:57 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 480 | $15.65 | 71,096 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:57 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 13,755 | $0 | 71,096 (Direct) | View |
2024-09-01 Option Award | 2024-09-04 8:55 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 154,700 | $0 | 390,041 (Direct) | View |
2024-09-01 Tax Withholding | 2024-09-04 8:55 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 11,144 | $26.74 | 390,041 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:55 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 39,517 | $0 | 390,041 (Direct) | View |
2024-09-01 Option Award | 2024-09-04 8:53 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 43,281 | $0 | 180,490 (Direct) | View |
2024-09-01 Tax Withholding | 2024-09-04 8:53 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 1,899 | $26.74 | 180,490 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:53 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,962 | $0 | 180,490 (Direct) | View |
2024-09-01 Option Award | 2024-09-04 8:52 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 43,350 | $0 | 151,529 (Direct) | View |
2024-09-01 Tax Withholding | 2024-09-04 8:52 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 2,829 | $26.74 | 151,529 (Direct) | View |
2024-09-03 Exercise | 2024-09-04 8:52 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 60,217 | $1.86 | 151,529 (Direct) | View |
2024-09-03 Exercise | 2024-09-04 8:52 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 475 | $3.8 | 151,529 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:52 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 70,659 | $0 | 151,529 (Direct) | View |
2024-09-01 Option Award | 2024-09-04 8:51 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 39,515 | $0 | 74,972 (Direct) | View |
2024-09-01 Tax Withholding | 2024-09-04 8:51 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 3,216 | $26.74 | 74,972 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:51 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 10,749 | $0 | 74,972 (Direct) | View |
2024-09-01 Option Award | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 43,062 | $0 | 125,037 (Direct) | View |
2024-09-01 Tax Withholding | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,738 | $26.74 | 125,037 (Direct) | View |
2024-09-03 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 29,730 | $11.1 | 125,037 (Direct) | View |
2024-07-15 Option Award | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 211 | $15.65 | 125,037 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 77,678 | $0 | 125,037 (Direct) | View |
2024-09-03 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 24,776 | $11.97 | 125,037 (Direct) | View |
2024-09-03 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 14,000 | $8.83 | 125,037 (Direct) | View |
2024-08-27 Exercise | 2024-08-29 4:36 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $1.59 | 165,928 (Direct) | View |
2024-08-27 Exercise | 2024-08-29 4:36 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals International plc | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 10,000 | $0 | 165,928 (Direct) | View |
2024-07-23 Exercise | 2024-07-25 4:33 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 136,124 | $1.59 | 361,954 (Direct) | View |
2024-07-23 Exercise | 2024-07-25 4:33 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals International plc | KNSA | Patel Sanj K CHAIRMAN & CEO | 136,124 | $0 | 361,954 (Direct) | View |
2024-07-23 Exercise | 2024-07-25 4:32 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 24,248 | $11.1 | 59,665 (Direct) | View |
2024-07-23 Exercise | 2024-07-25 4:32 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals International plc | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 24,248 | $0 | 59,665 (Direct) | View |
2024-07-23 Exercise | 2024-07-25 4:31 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 22,000 | $1.86 | 108,020 (Direct) | View |
2024-07-23 Exercise | 2024-07-25 4:31 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals International plc | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 22,000 | $0 | 108,020 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:41 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 22,213 | $0 | 31,586 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 4:41 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 4,373 | $0 | 31,586 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:40 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 22,213 | $0 | 35,110 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 4:40 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 4,373 | $0 | 35,110 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:39 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 22,213 | $0 | 103,553 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 4,373 | $0 | 103,553 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:37 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 22,213 | $0 | 31,586 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 4:37 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 4,373 | $0 | 31,586 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:36 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 22,213 | $0 | 31,586 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 4:36 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 4,373 | $0 | 31,586 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:35 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 22,213 | $0 | 31,586 (Direct) | View |
2024-06-06 Exercise | 2024-06-07 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 4,373 | $0 | 31,586 (Direct) | View |
2024-06-05 Option Award | 2024-06-07 4:07 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 82,506 | $0 | 2,831,529 (Indirect) | View |
2024-05-03 Option Award | 2024-05-07 4:46 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 747 | $0 | 9,271 (Direct) | View |
2024-05-03 Exercise | 2024-05-07 4:46 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 747 | $0 | 9,271 (Direct) | View |
2024-04-26 Tax Withholding | 2024-04-30 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 509 | $17.88 | 20,243 (Direct) | View |
2024-04-26 Exercise | 2024-04-30 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 991 | $0 | 20,243 (Direct) | View |
2024-04-04 Option Award | 2024-04-08 5:22 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 174,700 | $0 | 401,351 (Direct) | View |
2024-04-08 Tax Withholding | 2024-04-08 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 4,075 | $17.9 | 401,351 (Direct) | View |
2024-04-08 Exercise | 2024-04-08 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 9,992 | $0 | 401,351 (Direct) | View |
2024-04-04 Option Award | 2024-04-08 5:21 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 48,950 | $0 | 111,000 (Direct) | View |
2024-04-08 Tax Withholding | 2024-04-08 5:21 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 733 | $17.9 | 111,000 (Direct) | View |
2024-04-08 Exercise | 2024-04-08 5:21 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 2,497 | $0 | 111,000 (Direct) | View |
2024-04-04 Option Award | 2024-04-08 5:20 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 44,607 | $0 | 77,549 (Direct) | View |
2024-04-08 Tax Withholding | 2024-04-08 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 791 | $17.9 | 77,549 (Direct) | View |
2024-04-08 Exercise | 2024-04-08 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 2,694 | $0 | 77,549 (Direct) | View |
2024-04-04 Option Award | 2024-04-08 5:19 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 48,631 | $0 | 79,058 (Direct) | View |
2024-04-08 Tax Withholding | 2024-04-08 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,353 | $17.9 | 79,058 (Direct) | View |
2024-04-08 Exercise | 2024-04-08 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,477 | $0 | 79,058 (Direct) | View |
2024-04-04 Option Award | 2024-04-08 5:18 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 28,350 | $0 | 70,540 (Direct) | View |
2024-04-08 Tax Withholding | 2024-04-08 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 1,666 | $17.9 | 70,540 (Direct) | View |
2024-04-08 Exercise | 2024-04-08 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 3,932 | $0 | 70,540 (Direct) | View |
2024-04-04 Option Award | 2024-04-08 5:17 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 48,866 | $0 | 189,781 (Direct) | View |
2024-04-08 Tax Withholding | 2024-04-08 5:17 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 801 | $17.9 | 189,781 (Direct) | View |
2024-04-08 Exercise | 2024-04-08 5:17 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 2,726 | $0 | 189,781 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 5:25 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,750 | $0 | 22,118 (Direct) | View |
2024-04-01 Tax Withholding | 2024-04-03 5:25 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 514 | $19.7 | 22,118 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 5:23 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 1,773 | $0 | 129,417 (Direct) | View |
2024-04-01 Tax Withholding | 2024-04-03 5:23 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 521 | $19.7 | 129,417 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 6,482 | $0 | 186,333 (Direct) | View |
2024-04-01 Tax Withholding | 2024-04-03 5:22 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 1,903 | $19.7 | 186,333 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 5:21 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 2,558 | $0 | 26,734 (Direct) | View |
2024-04-01 Tax Withholding | 2024-04-03 5:21 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 1,084 | $19.7 | 26,734 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,612 | $0 | 19,985 (Direct) | View |
2024-04-01 Tax Withholding | 2024-04-03 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 880 | $19.7 | 19,985 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 1,624 | $0 | 50,911 (Direct) | View |
2024-04-01 Tax Withholding | 2024-04-03 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 477 | $19.7 | 50,911 (Direct) | View |